Predictors of clinical evolution of SARS‐CoV‐2 infection in hematological patients: A systematic review and meta‐analysis
E Carrara, E Razzaboni, AM Azzini… - Hematological …, 2023 - Wiley Online Library
Main aim of this systematic review is to quantify the risk and identify predictors of clinical
evolution of SARS‐CoV‐2 in hematological patients compared to different control …
evolution of SARS‐CoV‐2 in hematological patients compared to different control …
[HTML][HTML] Impact of COVID-19 in patients with lymphoid malignancies
JC Riches - World Journal of Virology, 2021 - ncbi.nlm.nih.gov
The first cases of coronavirus disease 2019 (COVID-19) were detected in Wuhan, China, in
December 2019. Since this time a concerted global effort of research and observational data …
December 2019. Since this time a concerted global effort of research and observational data …
COVID 19 and febrile neutropenia: Case report and systematic review
T Kaya, A Dilek, R Ozaras, OS Balcik… - Travel Medicine and …, 2022 - Elsevier
Objectives In pandemic conditions, patients with febrile neutropenia are also at risk of
COVID-19. Aim of this systematic review is to evaluate COVID-19 cases presented with …
COVID-19. Aim of this systematic review is to evaluate COVID-19 cases presented with …
The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants
Q Wu, S Luo, X Xie - BMC cancer, 2022 - Springer
Background This study was designed to investigate the impact of anti-tumor approaches
(including chemotherapy, targeted therapy, endocrine therapy, immunotherapy, surgery and …
(including chemotherapy, targeted therapy, endocrine therapy, immunotherapy, surgery and …
Outcome of COVID‐19 in patients with chronic myeloid leukemia: A single centre UK experience.
G Nesr, Z Saleem, S Arami - Journal of Medical Virology, 2022 - search.ebscohost.com
Abstract COVID-19 in patients (pts) with chronic myeloid leukemia (CML): results from the
international CML foundation (iCMLf) CML and COVID-19 (CANDID) study. Similarly, in …
international CML foundation (iCMLf) CML and COVID-19 (CANDID) study. Similarly, in …
[PDF][PDF] East African Scholars Journal of Medicine and Surgery
AF Kombo, XY Ji - 2024 - easpublisher.com
Cancer is among the fatal diseases caused by abnormal cell growth from one organ that can
invade and destroy adjacent organs. These abnormally growing cells are caused by defects …
invade and destroy adjacent organs. These abnormally growing cells are caused by defects …
Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust
R Hinton, G Nesr, C Garnett, D Foldes… - Leukemia & …, 2022 - Taylor & Francis
The UK has been severely affected by the COVID-19 pandemic with over 4.4 million cases
and over 127,000 deaths to date (www. gov. uk accessed 17 May 2021). Patients with …
and over 127,000 deaths to date (www. gov. uk accessed 17 May 2021). Patients with …
[HTML][HTML] Concurrent Lymphoma and COVID-19: Diagnostic and Therapeutic Challenges of High-Grade Lymphoma and COVID-19
J Hundal, AR Vartanov, K Huh, E Ballesteros, V Forbes - Cureus, 2022 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) global pandemic has put an
unprecedented strain on cancer care. The initial months were marred by fears of …
unprecedented strain on cancer care. The initial months were marred by fears of …